NCT02539303View on ClinicalTrials.gov

Delivery of Yamani-15/5 Chemical Solution for PAD

PHASE1WithdrawnINTERVENTIONAL

0

Timeline

Start Date

August 31, 2015

Primary Completion Date

August 31, 2022

Study Completion Date

August 31, 2023

Conditions

Peripheral Arterial Disease

Interventions

DRUG

Yamani-15/5 chemical solution

A 20 ml of Yamani-15/5 will be directly infused into the diseased (calcific) arterial distribution.

Sponsors

Lead Sponsor

All Listed Sponsors

lead

Mayo Clinic

OTHER